Deepak Nitrite Elevates Shri Maulik Mehta to Deputy Managing Director Effective May 9, 2026

2 min read     Updated on 10 May 2026, 03:16 AM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Deepak Nitrite Limited has elevated Shri Maulik Mehta (DIN: 05227290) to Deputy Managing Director effective May 9, 2026, for a five-year term, following the conclusion of his tenure as Executive Director & CEO on May 8, 2026. The appointment, first intimated on April 3, 2026, was confirmed via regulatory filings to NSE and BSE under Regulation 30 of SEBI (LODR) Regulations, 2015. Shri Mehta, with 18 years of experience and academic credentials from Liverpool, Columbia, and Harvard, has been instrumental in the Company's ESG and 'Depend on Deepak' strategic initiatives.

powered bylight_fuzz_icon
39854458

*this image is generated using AI for illustrative purposes only.

Deepak Nitrite Limited has announced the re-appointment and elevation of Shri Maulik Mehta as Deputy Managing Director of the Company, effective May 9, 2026, for a period of 5 (five) years. The development was communicated to both BSE Limited and the National Stock Exchange of India Limited under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Shri Mehta's previous tenure as Executive Director & Chief Executive Officer concluded on May 8, 2026, upon which he ceased to hold that position. The appointment had been first intimated to the stock exchanges on April 3, 2026, subject to shareholder approval, and has now become effective.

Leadership Transition Details

The appointment details, as disclosed in the regulatory filing, are summarised below:

Parameter: Details
Name of Director: Shri Maulik Mehta
DIN: 05227290
Previous Role: Executive Director & Chief Executive Officer
New Role: Deputy Managing Director
Effective Date: May 9, 2026
Term of Appointment: 5 (five) years
Reason for Change: Completion of term as Executive Director & CEO on May 8, 2026; re-appointment and elevation as Deputy Managing Director

Shri Maulik Mehta is not debarred from holding the office of a Director by virtue of any SEBI Order or any other such authority.

Profile of Shri Maulik Mehta

Shri Maulik Mehta holds a Bachelor of Business Administration from the University of Liverpool, UK, and a Master's degree in Industrial and Organisational Psychology from Columbia University, USA. He has also completed the Owner/President Management programme — an executive MBA programme — from Harvard Business School. His academic background spans business administration, organisational psychology, and executive leadership.

Shri Mehta brings 18 years of hands-on, outcome-driven experience across key functional areas, including:

  • Business development
  • Patent and product development
  • Human resources
  • Brand equity
  • External relations

He assumed leadership during the peak of the COVID-19 pandemic, prioritising workforce security, healthcare, and investor interest protection. He is recognised as an ESG champion, having led the Company's adoption of "Responsible Chemistry" as a guiding principle encompassing diversity, equity, inclusion, circularity, and sustainability.

Strategic Initiatives and Vision

Shri Maulik Mehta has played a pivotal role in shaping the Company's vision to become India's leading intermediate chemical manufacturer through the "Depend on Deepak" initiative. This initiative focuses on building a strong organisation through efficient processes and systems, with an emphasis on ethical and transparent practices, aimed at assuring shareholders, customers, and employees of a dependable, stable, and transparent future.

Disclosure of Relationships

As required under SEBI regulations, the Company has disclosed the following familial relationships between Shri Maulik Mehta and other directors:

Relationship: Director
Son of: Shri Deepak C. Mehta, Chairman and Managing Director
Brother of: Shri Meghav Mehta, Deputy Managing Director
Nephew of: Shri Ajay C. Mehta, Non-Executive Director

The intimation was signed by Arvind Bajpai, Company Secretary, on May 9, 2026, and filed with the stock exchanges in compliance with applicable SEBI disclosure requirements.

Historical Stock Returns for Deepak Nitrite

1 Day5 Days1 Month6 Months1 Year5 Years
-0.66%+7.29%+30.99%+8.31%-2.13%+4.94%

With both Maulik Mehta and Meghav Mehta now serving as Deputy Managing Directors, how might Deepak Nitrite's leadership structure evolve as the company prepares for a potential future succession from Chairman Deepak C. Mehta?

How could Maulik Mehta's elevation to Deputy Managing Director influence Deepak Nitrite's strategic expansion plans in the specialty chemicals and intermediate chemicals segments over the next five years?

Given the concentrated family leadership at Deepak Nitrite, how might institutional investors and proxy advisory firms respond to governance concerns, and could this impact the company's ESG ratings?

Deepak Nitrite Subsidiaries Complete ₹150 Crore Inter-Company Share Allotment

2 min read     Updated on 01 May 2026, 07:15 AM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Deepak Nitrite Limited announced that its wholly owned subsidiary Deepak Chem Tech Limited (DCTL) has allotted 1,50,00,000 9% Optionally Convertible Redeemable Preference Shares worth ₹150.00 crores to another wholly owned subsidiary Deepak Phenolics Limited (DPL) on April 30, 2026. The transaction, conducted at par value of ₹100 per share through normal banking channels, aims to strengthen DCTL's capital base and support project expenses across Gujarat sites. DCTL operates specialized chemical manufacturing facilities and reported a turnover of ₹9.43 crores in FY 2024-25.

powered bylight_fuzz_icon
39108856

*this image is generated using AI for illustrative purposes only.

Deepak Nitrite Limited has announced a significant inter-company transaction between its wholly owned subsidiaries on April 30, 2026. The company disclosed that Deepak Chem Tech Limited (DCTL) has issued and allotted 1,50,00,000 9% Optionally Convertible Redeemable Preference Shares (OCRPS) worth ₹150.00 crores to Deepak Phenolics Limited (DPL). The transaction was conducted in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Transaction Details

The preference shares were allotted at par value, with each share priced at ₹100. The transaction represents a related party arrangement between two wholly owned subsidiaries of Deepak Nitrite Limited, conducted on an arms-length basis through normal banking channels.

Parameter: Details
Share Type: 9% Optionally Convertible Redeemable Preference Shares
Number of Shares: 1,50,00,000
Face Value per Share: ₹100
Total Value: ₹150.00 crores
Allotment Date: April 30, 2026

About Deepak Chem Tech Limited

DCTL, incorporated on October 9, 2020, operates specialized chemical manufacturing facilities across Gujarat. The company runs plants for Fluorination, Nitric Acid, Nitration and Hydrogenation processes while pursuing various expansion projects. Prior to this allotment, DCTL maintained a paid-up capital of ₹2234.50 crores, comprising ₹499.50 crores in equity shares and ₹1735 crores in preference shares.

Financial Year: Turnover
FY 2024-25: ₹9.43 crores
FY 2023-24: ₹0.86 crores
FY 2022-23: Not Available

Purpose and Impact

The fund infusion serves multiple strategic objectives for strengthening DCTL's operational capabilities. The primary purposes include:

  • Strengthening the capital base of DCTL
  • Supporting project expenses across various Gujarat sites
  • Meeting general corporate requirements
  • Enhancing financial flexibility for ongoing operations

The transaction maintains the existing ownership structure, with Deepak Nitrite Limited continuing to hold 100% equity share capital in DCTL. Combined with DPL, the parent company maintains indirect 100% control over DCTL's preference share capital.

Regulatory Compliance

The allotment required no governmental or regulatory approvals beyond standard disclosure requirements. The transaction falls under related party arrangements as both DCTL and DPL are wholly owned subsidiaries operating within the chemical industry sector. The business activities of DCTL align with Deepak Nitrite Limited's main line of operations, ensuring strategic coherence within the group structure.

Official Disclosure

The transaction was officially communicated to the National Stock Exchange of India Limited on April 30, 2026, under reference DNL/140/NSE/1650/2026. The disclosure confirmed that 1,50,00,000 OCRPS aggregating to ₹150.00 Crores were allotted by DCTL to DPL on the same date. The consideration was paid in cash through normal banking channels, and no governmental or regulatory approvals were required for the investment. The allotment was made at par value of ₹100 per share, maintaining the arms-length nature of the transaction between related parties.

Sr. No. Particulars Details
1 Nature of consideration Cash by way of transfer of money by normal banking channel
2 Cost of acquisition ₹100 per share, aggregating to ₹150 Crores
3 Shareholding post-allotment Deepak Nitrite Limited continues to hold 100% of Equity Share Capital of DCTL
4 Date of Incorporation of DCTL October 9, 2020
5 Industry Chemical Industry
6 Presence India

Historical Stock Returns for Deepak Nitrite

1 Day5 Days1 Month6 Months1 Year5 Years
-0.66%+7.29%+30.99%+8.31%-2.13%+4.94%

What specific expansion projects at DCTL's Gujarat facilities will benefit from this ₹150 crore capital infusion?

How might this significant preference share allotment impact Deepak Nitrite's consolidated debt-to-equity ratio and credit ratings?

Will DCTL consider converting these 9% OCRPS to equity shares given the current interest rate environment and company's growth trajectory?

More News on Deepak Nitrite

1 Year Returns:-2.13%